In the Original Investigation entitled “Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial”1 published in the April 3, 2018, issue of JAMA, an error occurred in a figure. In Figure 3, the last 2 row labels were switched. The second-to-last row should have been labeled “Bare-metal stent only” and the last row should have been labeled “≥1 Drug-eluting stent.” This article was corrected online.
Reference
- 1.Berwanger O, Santucci EV, de Barros E Silva PGM, et al. ; SECURE-PCI Investigators . Effect of loading dose of atorvastatin prior to planned percutaneous coronary intervention on major adverse cardiovascular events in acute coronary syndrome: the SECURE-PCI randomized clinical trial. JAMA. 2018;319(13):1331-1340. doi: 10.1001/jama.2018.2444 [DOI] [PMC free article] [PubMed] [Google Scholar]